{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:18:46Z","timestamp":1762078726050},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1007\/bf02090216","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T16:28:16Z","timestamp":1124036896000},"page":"410-417","source":"Crossref","is-referenced-by-count":37,"title":["Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Martin J.","family":"Collen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02090216_CR1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0016-5085(81)80072-8","volume":"81","author":"WJ Dodds","year":"1981","unstructured":"Dodds WJ, Hogan WJ, Helm JF, Dent J: Pathogenesis of reflux esophagitis. Gastroenterology 81:376\u2013394, 1981","journal-title":"Gastroenterology"},{"key":"BF02090216_CR2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198212163072503","volume":"308","author":"WJ Dodds","year":"1982","unstructured":"Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK, Egide MS: Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 308:1547\u20131552, 1982","journal-title":"N Engl J Med"},{"key":"BF02090216_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.1985.00360020173027","volume":"145","author":"F Navab","year":"1985","unstructured":"Navab F, Textor EC: Gastroesophageal reflux: Pathopsychologic concepts. Arch Intern Med 145:329\u2013333, 1985","journal-title":"Arch Intern Med"},{"key":"BF02090216_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-97-1-93","volume":"97","author":"JE Richter","year":"1982","unstructured":"Richter JE, Castell DO: Gastroesophageal reflux: Pathogenesis, diagnosis, and therapy. Ann Intern Med 97:93\u2013103, 1982","journal-title":"Ann Intern Med"},{"key":"BF02090216_CR5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0016-5085(90)90285-9","volume":"98","author":"MJ Collen","year":"1990","unstructured":"Collen MJ, Lewis JH, Benjamin SB: Gastric acid hypersecretion and refractory gastroesophageal reflux disease. Gastroenterology 98:654\u2013661, 1990","journal-title":"Gastroenterology"},{"key":"BF02090216_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/00365528609015167","volume":"21","author":"KE Johansson","year":"1986","unstructured":"Johansson KE, Tibbling L: Gastric secretion and reflux pattern in reflux esophagitis before and during ranitidine therapy. Scand J Gastroenterol 21:487\u2013492, 1986","journal-title":"Scand J Gastroenterol"},{"key":"BF02090216_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archsurg.1989.01410080069011","volume":"124","author":"AP Barlow","year":"1989","unstructured":"Barlow AP, DeMeester TM, Ball CS, Eypasch EP: The significance of gastric secretory state in gastroesophageal reflux disease. Arch Surg 124:937\u2013940, 1989","journal-title":"Arch Surg"},{"key":"BF02090216_CR8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0016-5085(91)90062-P","volume":"101","author":"BI Hirschowitz","year":"1991","unstructured":"Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149\u20131158, 1991","journal-title":"Gastroenterology"},{"key":"BF02090216_CR9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF01307581","volume":"37","author":"MJ Collen","year":"1992","unstructured":"Collen MJ, Johnson DA: Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus. Dig Dis Sci 37:570\u2013571, 1992","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/BF01538064","volume":"34","author":"MW Mulholland","year":"1989","unstructured":"Mulholland MW, Reid BJ, Levine DS, Rubin CE: Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci 34:1329\u20131335, 1989","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF01296251","volume":"29","author":"TE Knuff","year":"1984","unstructured":"Knuff TE, Benjamin SB, Worsham GF, Hancock JE, Castell DO: Histologic evaluation of chronic gastroesophageal reflux: An evaluation of biopsy methods and diagnostic criteria. Dig Dis Sci 29:194\u2013201, 1984","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJM198608073150605","volume":"315","author":"SJ Spechler","year":"1986","unstructured":"Spechler SJ, Goyal RK: Barrett's esophagus. N Engl J Med 315:362\u2013371, 1986","journal-title":"N Engl J Med"},{"key":"BF02090216_CR13","first-page":"1350","volume":"92","author":"MJ Collen","year":"1987","unstructured":"Collen MJ, Ciarleglio CA, Stanczak VG, Lewis JH, Cattau EL, Fleischer DE, Benjamin SB: Basal acid output in patients with gastroesophageal reflux disease. Gastroenterology 92:1350, 1987 (abstract)","journal-title":"Gastroenterology"},{"key":"BF02090216_CR14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/BF01296801","volume":"36","author":"MJ Collen","year":"1991","unstructured":"Collen MJ, Sheridan MJ: Definition for idiopathic gastric acid hypersecretion: A statistical and functional evaluation. Dig Dis Sci 36:1371\u20131376, 1991","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-75858-4_12","volume-title":"Handbook of Experimental Pharmacology, Vol 99, Pharmacology of Peptic Ulcer Disease","author":"MJ Collen","year":"1991","unstructured":"Collen MJ: Idiopathic gastric acid hypersecretion.In Handbook of Experimental Pharmacology, Vol 99, Pharmacology of Peptic Ulcer Disease. MJ Collen, SB Benjamin (eds). Springer-Verlag, Heidelberg, 1991, pp 325\u2013348"},{"key":"BF02090216_CR16","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/0016-5085(92)90366-7","volume":"102","author":"MJ Collen","year":"1992","unstructured":"Collen MJ, Johnson DA, Sheridan MJ: Basal acid output in gastroesophageal reflux disease. Gastroenterology 102:2182\u20132183, 1992 (letter, reply)","journal-title":"Gastroenterology"},{"key":"BF02090216_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01536057","volume":"34","author":"MJ Collen","year":"1989","unstructured":"Collen MJ, Stanczak VJ, Ciarleglio CA: Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). Dig Dis Sci 34:233\u2013237, 1989","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2036.1989.tb00212.x","volume":"3","author":"NJ Johnson","year":"1989","unstructured":"Johnson NJ, Boyd EJS, Mills JG, Wood JR: Acute treatment of reflux esophagitis: a multicenter trial to compare 150 mg ranitidine, bd with 300 mg ranitidine qds. Aliment Pharmacol Ther 3:259\u2013266, 1989","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090216_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2036.1988.tb00692.x","volume":"2","author":"WC Orr","year":"1988","unstructured":"Orr WC, Robinson MG, Humphries TJ: Dose ranging effects of famotidine on gastric acid suppression. Aliment Pharmacol Ther 2:229\u2013235, 1988","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090216_CR20","first-page":"63","volume":"100","author":"HPM Festen","year":"1991","unstructured":"Festen HPM, Wesdorp ICE, Dekker W: The efficacy of famotidine 20 mg bid versus 40 mg bid in the treatment of erosive\/ulcerative reflux esophagitis: Significance of severity of esophagitis and duration of therapy. Gastroenterology 100:63, 1991 (abstract)","journal-title":"Gastroenterology"},{"key":"BF02090216_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000200104","volume":"44","author":"SGM Meuwissen","year":"1989","unstructured":"Meuwissen SGM, Klinkenberg-Knol EC: Management of gastroesophageal reflux disease\u2014are there alternatives to omeprazole? Digestion 44:54\u201362, 1989","journal-title":"Digestion"},{"issue":"suppl","key":"BF02090216_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.1991.tb00749.x","volume":"5","author":"DO Castell","year":"1991","unstructured":"Castell DO: Rational for high-dose H2-receptor blockade in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 5(suppl):59\u201367, 1991","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090216_CR23","first-page":"457","volume":"13","author":"P Zeitoun","year":"1989","unstructured":"Zeitoun P, Rampal P, Barbeir P: Omeprazole vs ranitidine in the treatment of reflux esophagitis. Results of a randomized, double-blind, multicenter French-Belgian study. Gastroenterol Clin Biol 13:457\u2013462, 1989","journal-title":"Gastroenterol Clin Biol"},{"key":"BF02090216_CR24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365528809093923","volume":"23","author":"S Sandmark","year":"1988","unstructured":"Sandmark S, Carlsson R, Fausal O, Lundell L: Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind Scandinavian multicenter study. Scand J Gastroenterol 23:625\u2013632, 1988","journal-title":"Scand J Gastroenterol"},{"key":"BF02090216_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.296.6615.89","volume":"296","author":"T Haveland","year":"1988","unstructured":"Haveland T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, Fenger C, Hanberg-Sorensen F, Lauritsen K: Omeprazole and ranitidine in the treatment of reflux esophagitis: Double-blind comparative trial. BMJ 296:89\u201392, 1988","journal-title":"BMJ"},{"key":"BF02090216_CR26","first-page":"914","volume":"83","author":"FI Lee","year":"1988","unstructured":"Lee FI, Isaacs PET: Barrett's ulcer: Response to standard dose ranitidine, high dose ranitidine and omeprazole. Am J Gastroenterol 83:914\u2013916, 1988","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"BF02090216_CR27","first-page":"764","volume":"81","author":"W Hameetman","year":"1986","unstructured":"Hameetman W, Tytgat GN: Healing of chronic Barrett's ulcers with omeprazole. Am J Gastroenterol 81(9):764\u2013766, 1986","journal-title":"Am J Gastroenterol"},{"key":"BF02090216_CR28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF01798351","volume":"33","author":"G Vantrappen","year":"1988","unstructured":"Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts J-L: Omeprazole (40 mg) is superior to ranitidine in the short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 33:523\u2013529, 1988","journal-title":"Dig Dis Sci"},{"key":"BF02090216_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(87)91726-0","volume":"1","author":"EC Klinkenberg-Knol","year":"1987","unstructured":"Klinkenberg-Knol EC, Jansen JBMJ, Festen HPM, Meuwissen SGM, Lamers CBHW: Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1:349\u2013351, 1987","journal-title":"Lancet"},{"issue":"suppl","key":"BF02090216_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00365528909091254","volume":"166","author":"G Bruner","year":"1989","unstructured":"Bruner G, Grutzfeldt W: Omeprazole in the long-term management of patients with acid related diseases resistant to ranitidine. Scand J Gastroenterol 166(suppl):101\u2013105, 1989","journal-title":"Scand J Gastroenterol"},{"issue":"suppl","key":"BF02090216_CR31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/00365528909091290","volume":"24","author":"J Dent","year":"1989","unstructured":"Dent J, Klinkenberg-Knol EC, Elm G, Eriksson K, Rikner L, Solvell L: Omeprazole in the long term management of patients with reflux esophagitis, refractory to histamine H2-receptor antagonists. Scand J Gastroenterol 24(suppl):176, 1989","journal-title":"Scand J Gastroenterol"},{"issue":"suppl","key":"BF02090216_CR32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00365528909091291","volume":"24","author":"KD Bardhan","year":"1989","unstructured":"Bardhan KD, Morris P, Thompson M, Dhande D, Hinchliffe RFC, Daly MJ, Carroll NJH, Krakowczyk C: Omeprazole in the treatment of erosive esophagitis, refractory to high dose cimetidine. Scand J Gastroenterol 24(suppl):177, 1989","journal-title":"Scand J Gastroenterol"},{"issue":"suppl","key":"BF02090216_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000200216","volume":"44","author":"EC Klinkenberg-Knol","year":"1989","unstructured":"Klinkenberg-Knol EC, Meuwissen SGM: Treatment of reflux esophagitis resistant to H2-receptor antagonists. Digestion 44(suppl):47\u201353, 1989","journal-title":"Digestion"},{"key":"BF02090216_CR34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/gut.31.7.745","volume":"31","author":"KD Bardhan","year":"1990","unstructured":"Bardhan KD, Morris P, Thompson M, Dhande DS, Hinchliffe RFC, Jones RB, Daly MJ, Carroll NJH: Omeprazole in the treatment of erosive esophagitis, refractory to high doses of cimetidine and ranitidine. Gut 31:745\u2013749, 1990","journal-title":"Gut"},{"key":"BF02090216_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.1990.tb00459.x","volume":"4","author":"L Lundell","year":"1990","unstructured":"Lundell L, Backman L, Extrom P: Omeprazole or high dose ranitidine in the treatment of patients with reflux esophagitis, not responding to standard doses of H2-receptor antagonists. Aliment Pharmacol Ther 4:145\u2013155, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090216_CR36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2036.1990.tb00507.x","volume":"4","author":"H Koop","year":"1990","unstructured":"Koop H, Hotz J, Pominer G, Klein M, Arnold R: Prospective evaluation of omeprazole treatment in reflux esophagitis refractory to H2-receptor antagonists. Aliment Pharmacol Ther 4:593\u2013599, 1990","journal-title":"Aliment Pharmacol Ther"},{"key":"BF02090216_CR37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/BF01300388","volume":"37","author":"MJ Collen","year":"1992","unstructured":"Collen MJ, Strong RM: Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 37:897\u2013903, 1992","journal-title":"Dig Dis Sci"},{"issue":"suppl","key":"BF02090216_CR38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/00365529009093149","volume":"25","author":"JBMJ Jansen","year":"1990","unstructured":"Jansen JBMJ, Lamers CBHW: High doses of ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 25(suppl):42\u201346, 1990","journal-title":"Scand J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02090216\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02090216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T01:48:01Z","timestamp":1706492881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02090216"}},"subtitle":["Correlation with ranitidine therapy"],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["BF02090216"],"URL":"https:\/\/doi.org\/10.1007\/bf02090216","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}